Rett syndrome (RTT) is a severe neurodevelopmental disorder caused by mutations in the MECP2 gene, leading to various symptoms, including cognitive impairment, motor dysfunction, and significant respiratory abnormalities.
The disease is hallmarked by repetitive movements and general developmental regression, however cause of death is often due epileptic or respiratory crises.
Integrating vivoFlow plethysmography with easyTEL+ telemetry enables comprehensive, multi-parameter monitoring in RTT models by capturing respiratory, cardiovascular, neurological, and physiological data simultaneously.
This integrated approach allows researchers to gain a holistic view of RTT pathology and treatment effects, providing insights into disease progression that would be unattainable with single-modality setups. The easyTEL+ telemetry system complements plethysmography by adding ECG, EEG, EMG, body temperature, and activity data, which together create a detailed physiological profile:
easyTEL+ implantable telemetry can acquire multiple biopotentials, blood pressures, temperature, activity, and respiratory rate in small and large animals.
Transmitter state (on/sleep) and reconfigurable settings (sampling rate, resolution, transmission power, transmission frequency, etc.) can be controlled wirelessly. This reduces human interaction, thereby increasing the likelihood or the animal’s natural state during behavioral testing.
Breathing abnormalities are more common toward the end of regression and include both hyperventilation, and respiratory dysrhythmia with breath holding and difficulty in terminating inspirations. Most respiratory studies in knock-out animal models of Rett Syndrome focus on whole body plethysmography to assess breathing parameters after various environmental or genetic modifications.
Whole body plethysmography and digital telemetry can be combined on a synchronized platform, for concurrent analysis of respiratory and neurological data.